Cardinal (CAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's ...

The healthcare services company says it expects to bring in over $50 billion in specialty revenue in fiscal 2026.

Cardinal Health has introduced ContinuCare Pathway, a pharmacy-to-supplier referral pathway program designed to help retail ...

In recent days, Cardinal Health has drawn increased attention as analysts upgraded their views and commentators highlighted ...

Drug distributor Cardinal Health raised its 2026 profit forecast on Tuesday, driven ​by robust demand for specialty medicines ...

Choose Columbus Business First as a preferred news source to see more of our reporting on Google.

In a report released today, Elizabeth Anderson CFA from Evercore ISI maintained a Buy rating on Cardinal Health, with a price target of $250.00.

The drug distributors continue to relentlessly climb higher. There’s nothing, you know, people hate the pharma middleman.

Get the live share price of Cardinal Health Inc (CAH), including intraday charts, historical performance, key financials, and ...

Cardinal Health stock has reached an all-time high, hitting a price of $214.93. This milestone underscores a significant upward trend for the company, which has seen its stock rise by an impressive 68 ...

DUBLIN, Ohio, Oct. 30, 2025 /PRNewswire/ -- Cardinal Health today reported first quarter fiscal year 2026 revenues of $64 billion, an increase of 22% from the first quarter of fiscal year 2025. First ...

Drug distributor Cardinal Health on Tuesday forecast 2026 adjusted profit to be at least $10 per share, compared with its ...